Your institution may have access to this item. Find your institution then sign in to continue.
Title
Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes.
Authors
van Wijk, Jeroen P H; de Koning, Eelco J P; Castro Cabezas, Manuel; Rabelink, Ton J
Abstract
Increased postprandial lipemia is part of diabetic dyslipidemia and is associated with accelerated atherosclerosis. We investigated the effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone on postprandial lipemia in patients with type 2 diabetes.